Division of Key Lab of Animal Disease Diagnosis and Immunology of China's Department of Agriculture, Nanjing Agriculture University, Nanjing 210095, China.
Peptides. 2012 Feb;33(2):258-64. doi: 10.1016/j.peptides.2012.01.012. Epub 2012 Jan 24.
The bursa of Fabricius (BF) is the acknowledged central immune organ, which is important to the B cell differentiation and antibody production. However, due to difficult purification, the immunomodulatory peptides from BF were little reported. In this study, the extract samples of BF were taken to a chromatographic analysis by RP-HPLC. Five novel low molecular weight peptides were isolated from BF, with amino acid sequences of YEYAY, RMYEE, GPPAT, AGCCNG, and RRL, and named as Bursal pentapeptide (BPP)-III, -IV, -V, and Bursal hexapeptide (BHP), and Bursal tripeptide (BTP), respectively. BSP-I, BSP-II, BPP-I and BPP-II are recently reported to be the bursal-derived bioactive peptides. In this paper, we analyzed the chemical formula and characteristics of these nine bursal-derived peptides. The immunization comparative experiment verified the different immunomodulatory activity of these nine bursal peptides on antibody and cytokine productions. Furthermore, the results showed that at reachable concentrations, BPP-II and BPP-I induced antibody productions, lymphocyte viabilities and cytokine responses in different dose-dependent manner in the immunized mice model, respectively. These results provided important orientations for the comprehensively understanding and study of the humoral central immune system of human, and provided a novel insight on the treatment of serious disease and immune improvement of human.
法氏囊(BF)是公认的中央免疫器官,对 B 细胞分化和抗体产生很重要。然而,由于难以纯化,来自 BF 的免疫调节肽报道较少。在这项研究中,通过 RP-HPLC 对 BF 的提取物样品进行了色谱分析。从 BF 中分离出 5 种新型低分子量肽,其氨基酸序列为 YEYAY、RMYEE、GPPAT、AGCCNG 和 RRL,分别命名为法氏囊五肽(BPP)-III、-IV、-V 和法氏囊六肽(BHP)和法氏囊三肽(BTP)。BSP-I、BSP-II、BPP-I 和 BPP-II 是最近报道的法氏囊来源的生物活性肽。在本文中,我们分析了这 9 种法氏囊来源肽的化学公式和特性。免疫比较实验验证了这 9 种法氏囊肽对抗体和细胞因子产生的不同免疫调节活性。此外,结果表明,在可达到的浓度下,BPP-II 和 BPP-I 以不同的剂量依赖性方式诱导免疫小鼠模型中的抗体产生、淋巴细胞活力和细胞因子反应。这些结果为全面了解和研究人类体液中枢免疫系统提供了重要方向,并为严重疾病的治疗和人类免疫改善提供了新的思路。